# Oral Isotretinoin in Melasma a Randomized Controlled Trial

> **NCT06201624** · PHASE1 · UNKNOWN · sponsor: **Zagazig University** · enrollment: 40 (estimated)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Isotretinoin
- **DRUG:** Triple combination formula

## Key facts

- **NCT ID:** NCT06201624
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06201624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06201624, "Oral Isotretinoin in Melasma a Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06201624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*